DAIC

JANUARY 24, 2025

With over 95% of adult and congenital cardiac surgery procedures and a majority of lung cancer and esophageal cancer surgery in the U.S., the data and outcomes from the STS Database specialty registries provide true national benchmarks for clinical outcomes of cardiothoracic surgery.

Outcomes 52

Outcomes Coronary Artery Bypass Graft Cardiothoracic Medicare 52

Society of Thoracic Surgeons - Adult Cardiac

JANUARY 26, 2025

We wanted to examine our outcomes, and we were pleasantly surprised to find that the freedom from re-intervention was 91% at 10 years and 87% at 20 years. Congenital All Members Clinical Decision-Making Patient Outcomes Quality Improvement The main drawback of the Ross operation is failure of the autograft over time, Dr. Shetty said.

Aortic valve 83

Aortic valve Cardiothoracic Congenital Aortic 83

Journal of Clinical Investigation - Cardiology

SEPTEMBER 17, 2024

BACKGROUND Metastatic hormone-sensitive prostate cancer (mHSPC) is androgen dependent, and its treatment includes androgen deprivation therapy (ADT) with gonadal testosterone suppression.

Cancer 75

Cancer Pharmacology Physiology Outcomes 75

Journal of Clinical Investigation - Cardiology

JULY 1, 2024

Crosstalk between different types of ubiquitination results in distinct biological outcomes for proteins. Using high-throughput sequencing, we found that ubiquitin-conjugating enzyme E2 C (UBE2C) was overexpressed in bladder cancer (BCa) and was strongly associated with an unfavorable prognosis.

Cancer 96

Cancer Outcomes 96

HCPLive

JANUARY 5, 2024

Patients with lean NAFLD had fewer metabolic comorbidities but maintained similar risk of NASH, cirrhosis, nonliver cancer, and mortality compared to their overweight and obese counterparts.

BMI 105

BMI Obesity Cancer Outcomes 105

Journal of Cardiothoracic Surgery

JUNE 21, 2024

The question of whether segmentectomy and lobectomy have similar survival outcomes for patients with early-stage non-small cell lung cancer (NSCLC) is a matter of debate.

Cancer 52

Cancer Outcomes 52

Society of Thoracic Surgeons - Surgeon

OCTOBER 15, 2024

The esophagectomy for cancer risk calculator is powered by enhanced STS esophagectomy for cancer risk models using data from 18,503 patients across 254 hospitals between January 2015 and December 2022. Key updates include the incorporation of new risk factors such as preoperative cancer staging and body surface area.

Cancer 52

Cancer Risk Factors Hospital Research 52

Society of Thoracic Surgeons - Surgeon

OCTOBER 16, 2024

Resource Pulmonary Resection for Lung Cancer Risk Calculator gmckinney Wed, 10/16/2024 - 07:59 The new pulmonary resection for lung cancer risk calculator is engineered using contemporary data from the STS General Thoracic Surgery Database.

Cancer 52

Cancer Pulmonary Hospital Outcomes 52

Medical Xpress - Cardiology

FEBRUARY 14, 2025

Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, according to a new study being presented at ACC's Advancing the Cardiovascular Care of the Oncology Patient course.

Cancer 52

Cancer Atherosclerosis Risk Factors Heart Disease 52

Stroke Journal

JANUARY 30, 2025

Introduction:Comorbid active cancer among in-hospital onset acute ischemic stroke (IHS) is increasing. Patients characteristics, time course, of initial management and clinical outcome were compared in both groups. A good functional outcome was defined as modified Rankin Scale score 0-3.

Cancer 40

Cancer Hospital Outcomes Strokes 40

Journal of Cardiothoracic Surgery

FEBRUARY 3, 2024

Early-stage esophageal cancer is treated using endoscopic submucosal dissection and esophagectomy. Field cancerization in patients with early-stage esophageal cancer affects treatment outcomes and causes synch.

Cancer 52

Cancer Outcomes Research 52

ADN Center of Excellence

NOVEMBER 7, 2024

This field involves intricate surgeries on the heart, lungs, esophagus, and major blood vessels, requiring surgical precision, advanced knowledge, and a strong commitment to patient outcomes. Oncology Oncology fellowships are critical for those interested in addressing cancer, one of the most challenging and impactful diseases of our time.

Cancer 59

Cancer Academic Research Interventional Cardiology 59

Heart BMJ

JULY 25, 2024

Background Data on the management of patients with cancer presenting with sudden cardiac arrest (SCA) are scarce. We aimed to assess the characteristics and outcomes of SCA according to cancer history. Results Out of 4069 patients who had SCA admitted alive in hospital, 207 (5.1%) had current or past medical history of cancer.

Cardiac Arrest 52

Cardiac Arrest Cancer Hospital Embolism 52

Dr. Paddy Barrett

APRIL 11, 2025

More than heart disease or cancer, dementia is the primary concern for many of the patients I see. Heart disease and cancer attack your body, but dementia attacks your mind and identity. We always need to examine how the outcome we are interested in changes. It strips away the fabric of who a person is. How Much Exercise?

Dementia 76

Dementia Exercise Cancer Heart Disease 76

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2025

Recent advances in immunotherapy have significantly improved outcomes for cancer patients. However, therapies such as immune checkpoint inhibitors (ICIs) can lead to immune-related adverse events, including potentially fatal ICI-myocarditis.

Cardiothoracic 52

Cardiothoracic Cancer Outcomes 52

Stroke Journal

FEBRUARY 1, 2024

Introduction:Atrial fibrillation (AF) and cancer are both independently associated with worse outcomes in patients with acute ischemic stroke. Few studies have evaluated the impact of AF on outcomes of cancer-related stroke. The primary outcome was in-hospital mortality. The primary exposure was a diagnosis of AF.

Cancer 40

Cancer Atrial Fibrillation Outcomes Strokes 40

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Outcomes were worse with increasing surgical urgency, older age, dialysis dependence, and multiple reoperations.

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

DAIC

JANUARY 29, 2024

The researchers found that Medicare patients undergoing esophagectomy for cancer exhibit identifiable predictors for long-term survival and readmission. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.

Research 111

Research TAVR Aortic valve Atrial Fibrillation 111

Journal of Clinical Investigation - Cardiology

OCTOBER 15, 2024

The precise conditions by which cytokines drive cancer is relevant to improving immune checkpoint inhibition (ICI) responses while decreasing toxicity. The authors evaluated T cell populations, cytokine signatures, immune related adverse events (irAEs), and survival outcomes. In this issue of the JCI, Kao et al.

Cancer 95

Cancer Outcomes 95

Journal of Cardiothoracic Surgery

DECEMBER 19, 2024

The prognosis of patients with synchronous oligometastatic non-small cell lung cancer (NSCLC) has been improving owing to advancements in imaging techniques and new treatment approaches such as tyrosine kinase.

Cancer 52

Cancer Outcomes Research 52

HCPLive

MARCH 17, 2025

Patients with CKD undergoing radical prostatectomy for prostate cancer experienced greater rates of adverse in-hospital outcomes.

Hospital 52

Hospital Outcomes Cancer 52

Medical Xpress - Cardiology

JULY 11, 2024

New research from the University of Alberta offers the hope of better long-term outcomes for survivors of childhood cancer—and the path to those better outcomes is exercise.

Cancer 40

Cancer Research Exercise Outcomes 40

Stroke Journal

JANUARY 30, 2025

Strokes in cancer patients, particularly those with brain metastases, can often be overlooked or misattributed to other causes, making it vital to investigate this association further. Background:Cancer-related stroke (CRS) is a rare condition where a tumor or its metastasis can compress a blood vessel and result in stroke.

Cancer 40

Cancer Strokes Stroke Hemorrhage 40

DAIC

APRIL 9, 2024

Anthracyclines are a well-established class of cancer drugs that are used to treat several types of cancer. While they are effective at eradicating cancer, they are known to carry a risk of causing damage to the heart muscle. The PROACT study will continue to track outcomes in the study participants for at least 12 months.

ACE Inhibitor 105

ACE Inhibitor Cancer Biomarkers Heart Failure 105

Society of Thoracic Surgeons - Surgeon

NOVEMBER 3, 2023

While both trials showed similar results, there are important differences in design, demographics, and patients’ outcomes. The presenters will debate the nuances of the trials and their potential applications in clinical practice.

Cancer 52

Cancer Webinar Biomarkers Hospital 52

Circulation

NOVEMBER 11, 2024

Limited data indicate an elevated risk of atrial fibrillation (AF) after neoadjuvant chemoradiation in esophageal cancer however the role of AF as an independent predictor of outcomes post-esophagectomy remains under-studied. Outcomes over a 5-year period were mortality, ischemic stroke, and use of anticoagulation.

Atrial Fibrillation 40

Atrial Fibrillation Cancer Outcomes BMI 40

Journal of the American Heart Association

APRIL 16, 2025

BackgroundStrategies to estimate risk of cancer therapyrelated cardiac dysfunction (CTRCD) before initiating cardiotoxic cancer treatment are needed. Journal of the American Heart Association, Ahead of Print. Quantitative measurements of ECG waveform parameters were performed using MUSE (GE Healthcare).

Cancer 40

Cancer Echocardiogram Heart Failure Risk Factors 40

Circulation

NOVEMBER 11, 2024

Background:Cardiovascular disease is an important cause for mortality in cancer patients and cancer is a primary cause of non- cardiac mortality in patients with heart failure. Patients with a principal discharge diagnosis of heart failure were stratified into two groups based on presence of cancer. vs 3.1%; OR: 1.6;

Heart Failure 40

Heart Failure Cancer Hospital Outcomes 40

HeartRhythm

APRIL 30, 2024

Atrial arrhythmias (AA) are common in patients with pulmonary disease and various cancers. However, the association between AA and non-small cell lung cancer (NSCLC), and the impact of AA on overall clinical outcome in patients with NSCLC are not well-known.

Cancer 40

Cancer Arrhythmia Pulmonary Outcomes 40

Stroke Journal

JANUARY 30, 2025

However, there are no existing data supporting an independent relationship between cancer and atrial cardiopathy, another atrial pathology associated with increased acute ischemic stroke (AIS) risk. The study exposure was active cancer. Active cancer was present in 9.6% of patients with atrial cardiopathy (n=50/520) and 10.4%

Cancer 40

Cancer Strokes Stroke Atrial Fibrillation 40

HeartRhythm

APRIL 30, 2024

Furthermore the outcomes among patients with known cancer is not well documented. Transvenous lead extraction (TLE) is a revered procedure among Cardiologist.

Cancer 40

Cancer Document Outcomes 40

ADN Center of Excellence

NOVEMBER 14, 2024

Oncology Oncology fellowships delve into cancer care, focusing on advancements in chemotherapy, immunotherapy, and targeted treatments. These programs prepare physicians to lead in the fight against cancer, both in clinical and research settings.

Academic 59

Academic Interventional Cardiology Private Practice Innovation 59

Journal of Cardiovascular Pharmacology

JUNE 24, 2024

Their impact on the prognostic outcomes among cancer patients has been subject to scrutiny and debate. The aim of this study is to evaluate the effect of RASi on survival in cancer patients. Their impact on the prognostic outcomes among cancer patients has been subject to scrutiny and debate.

Cancer 40

Cancer Hypertension Outcomes Article 40

Journal of Clinical Investigation - Cardiology

JANUARY 16, 2024

Cancer remains a leading cause of mortality on a global scale. Lung cancer, specifically non–small cell lung cancer (NSCLC), is a prominent contributor to this burden. Although generally well tolerated, the administration of ICIs can result in unique side effects known as immune-related adverse events (irAEs).

Pulmonary 81

Pulmonary Cancer Outcomes 81

Journal of Clinical Investigation - Cardiology

MARCH 1, 2024

Chemotherapy, which primarily acts on cancer cells, can influence the tumor microenvironment and the recruitment and behavior of stromal cells. explored the potent anticancer effect of the combination of a glutaminase inhibitor (CB-839) and 5-FU against PIK3CA-mutant colorectal cancer tumors. In this issue of the JCI, Li et al.

Cancer 40

Cancer Outcomes 40

ECG Cases

JULY 30, 2024

A cultural shift emphasizing the importance of compassion in patient care needs to occur to improve outcomes of our patients and our job satisfaction; as such, compassion should be part of our training and CME. The post Compassionate Care to Improve Patient Outcomes and Your Career from EMU 2024 appeared first on Emergency Medicine Cases.

CME 52

CME Outcomes Cancer Patient Care 52

Circulation

NOVEMBER 11, 2024

Adverse CVD outcomes was defined as a composite of incident heart failure, incident atrial fibrillation / flutter, incident myocardial infarction or all-cause mortality. Adverse CVD outcomes was defined as a composite of incident heart failure, incident atrial fibrillation / flutter, incident myocardial infarction or all-cause mortality.

Cancer 40

Cancer Cardiovascular Disease Myocardial Infarction Atrial Fibrillation 40